KDR and neoplasm: This prevents the activation of both VEGF-A/VEGFR- and Ang-2/Tie2-mediated signaling pathways, resulting in the inhibition of proliferation of VEGF-A- and/or Ang-2-overexpressing tumor cells (263, 327).